UnitedHealth Group Incorporated filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 3, 2026, reporting financial results for the three and nine months ended September 30, 2026.

Key Highlights

  • Nine-month net earnings attributable to common shareholders: $15,874 million, compared to $12,046 million for the same period in 2025, according to the filing.
  • Third-quarter diluted EPS: $4.56 for Q3 2026, versus $2.59 for Q3 2025, as reported in the condensed consolidated statements of operations.
  • Total revenues, nine months ended September 30, 2026: $336,447 million, up from $334,352 million in the same period of 2025.
  • Total assets as of September 30, 2026: $312,782 million, compared to $309,581 million at December 31, 2025.
  • Medical costs payable: $39,352 million at September 30, 2026, essentially flat compared to $39,337 million at December 31, 2025.
  • Shares outstanding: 896,022,611 shares of common stock as of October 30, 2026, per the filing cover page.
  • Long-term debt: $68,714 million at September 30, 2026, down from $72,320 million at December 31, 2025.

UnitedHealth Group Third-Quarter 2026 Financial Results and Balance Sheet Position

According to the filing, UnitedHealth Group (NYSE:UNH) reported total revenues of $112,694 million for the three months ended September 30, 2026, compared to $113,161 million in the prior-year quarter. For the nine months ended September 30, 2026, total revenues were $336,447 million versus $334,352 million for the same period in 2025. Revenue components for the nine-month period included premiums of $261,595 million, products revenue of $41,378 million, services revenue of $30,043 million, and investment and other income of $3,431 million.

The filing disclosed earnings from operations of $6,563 million for Q3 2026, up from $4,315 million in Q3 2025. For the nine months ended September 30, 2026, earnings from operations totaled $23,544 million, compared to $18,584 million for the nine months ended September 30, 2025. Medical costs for the nine-month period were $225,829 million, down from $231,954 million in the comparable 2025 period. The provision for income taxes for the nine months ended September 30, 2026 was $4,004 million, versus $2,828 million for the same period in 2025.

On the balance sheet, the filing reported total assets of $312,782 million as of September 30, 2026, with goodwill of $112,974 million and other intangible assets, net, of $20,377 million. Total equity stood at $104,129 million, including retained earnings of $102,021 million and accumulated other comprehensive loss of $3,934 million. The filing also noted a loss on sale of subsidiary and subsidiaries held for sale of $209 million for the nine months ended September 30, 2026, compared to $139 million in the same period of 2025.

What Was Disclosed

UnitedHealth Group filed its quarterly report covering the period ended September 30, 2026, disclosing condensed consolidated financial statements, segment information, notes on medical costs payable, debt, commitments and contingencies, and held-for-sale items, among other matters required by SEC reporting rules.